Sign In
Buy FLDM
$1.83
+0 (+0%)
At Close: Jul 20, 2022
Hot Penny Stocks To Buy Now? 4 To Add To Your List Today
01:51pm, Friday, 12'th Nov 2021
Are these on your list of penny stocks to watch today? The post Hot Penny Stocks To Buy Now?
Biomark X Offers Industry-Leading Advantages in Speed, Throughput, Flexibility and Cost
08:30am, Thursday, 11'th Nov 2021
Streamlines Operations to Reduce Hands-On Time, Accelerate Results
Fluidigm Q3 Sales Trail Estimates; Cuts Annual Guidance As COVID-19 Sales Retreat
08:11am, Tuesday, 09'th Nov 2021
Fluidigm Corp (NASDAQ: FLDM) posted Q3 revenues of $28.5 million, down 29% Y/Y, missing the consensus of $30.00 million, citing supply chain issues affecting product fulfillment. Fluidigm is underta
Fluidigm Corporation (FLDM) CEO Chris Linthwaite on Q3 2021 Results - Earnings Call Transcript
10:18pm, Monday, 08'th Nov 2021
Fluidigm Corporation (FLDM) CEO Chris Linthwaite on Q3 2021 Results - Earnings Call Transcript
Fluidigm Announces Third Quarter 2021 Financial Results
04:02pm, Monday, 08'th Nov 2021
Board Undertaking Review of Range of Value-Enhancing Opportunities
Fluidigm Announces Conference Call and Webcast of Third Quarter 2021 Financial Results
08:30am, Wednesday, 20'th Oct 2021
SOUTH SAN FRANCISCO, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive healt
Fluidigm Announces New Co-Marketing Program under Collaboration Agreement with Visiopharm, Offering AI-Based Image Analysis Software
08:30am, Tuesday, 12'th Oct 2021
Native Reading of Hyperion Imaging System Data Files on the Visiopharm Platform to Streamline Data Analysis for Researchers Native Reading of Hyperion Imaging System Data Files on the Visiopharm Platf
Fluidigm Announces Collaboration Agreement with Karolinska Institutet to Accelerate Customer Adoption of New CyTOF XT
08:30am, Tuesday, 28'th Sep 2021
Department of Women's and Children's Health to Work with Fluidigm on CyTOF Research Applications, Product Development Department of Women's and Children's Health to Work with Fluidigm on CyTOF Researc
Fluidigm to Participate in the Cantor Virtual Global Healthcare Conference
08:30am, Thursday, 02'nd Sep 2021
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive heal
Fluidigm to Participate in UBS Genomics 2.0 and MedTech Innovations Summit
11:14am, Monday, 09'th Aug 2021
SOUTH SAN FRANCISCO, Calif., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive healt
Fluidigm Corporation (FLDM) CEO Chris Linthwaite on Q2 2021 Results - Earnings Call Transcript
10:35am, Sunday, 08'th Aug 2021
Fluidigm Corporation (FLDM) CEO Chris Linthwaite on Q2 2021 Results - Earnings Call Transcript
Fluidigm Q2 Earnings Ahead Of Street Expectations, But Sees Lower Revenues From COVID-19 Products
06:28am, Friday, 06'th Aug 2021
Fluidigm Corp's (NASDAQ: FLDM) second-quarter revenues grew 19% Y/Y to $31 million, edging out analysts' average expectation of $30.57 million. Base product and service revenue excluding COVID-19 te
Ultivue Announces Co-Marketing Agreement with Fluidigm for Biomarker Imaging Solutions for Precision Medicine
09:30am, Thursday, 05'th Aug 2021
CAMBRIDGE, Mass. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Ultivue, Inc. and Fluidigm Corporation (Nasdaq:FLDM) today announced a co-marketing agreement in which the companies will offer custome
Fluidigm Announces Co-Marketing Agreement with Ultivue for Biomarker Imaging Solutions for Precision Medicine
08:30am, Thursday, 05'th Aug 2021
Objective of Agreement is Comprehensive Portfolio for Biomarker Discovery and Drug Development Objective of Agreement is Comprehensive Portfolio for Biomarker Discovery and Drug Development
Fluidigm Stock Shoots Higher On Bloomberg Report Of Exploring Potential Sale
08:49am, Wednesday, 28'th Jul 2021
Fluidigm Corp (NASDAQ: FLDM) stock is trading higher in the premarket on a report that the Company is considering a sale. According to a Bloomberg report, the medical technology firm is working with
